Clinical trials
Phase 2 HIV Seropositivity trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2005 | 1 |
| 2006 | 1 |
| 2008 | 2 |
| 2010 | 3 |
| 2011 | 2 |
| 2012 | 1 |
| 2014 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2022 | 2 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 15 |
| Active, not recruiting | 2 |
| Not yet recruiting | 1 |
| Terminated | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AIM ImmunoTech Inc. | 2 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 2 |
| AIDS Malignancy Consortium | 1 |
| Bayside Health | 1 |
| BiondVax Pharmaceuticals ltd. | 1 |
| Centre Hospitalier Régional d'Orléans | 1 |
| Columbia University | 1 |
| Federal University of São Paulo | 1 |
| Friends Research Institute, Inc. | 1 |
| ImmunityBio, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| HIV Seropositivity | 20 |
| HIV Infections | 6 |
| Acquired Immunodeficiency Syndrome | 2 |
| Burkitt Lymphoma | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Diarrhea | 1 |
| Hodgkin Disease | 1 |
| Influenza, Human | 1 |
| Lupus Erythematosus, Systemic | 1 |
| Lymphoma, Large B-Cell, Diffuse | 1 |
Trials
Showing 26 to 20 of 20. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.